EXCLUSIVE: Imunon Says Enrollment Momentum for Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer Exceeds Expectations; Projects Enrollment to Complete in Q2 of 2029

뉴스 본문을 불러오고 있어요.

EXCLUSIVE: Imunon Says Enrollment Momentum for Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer Exceeds Expectations; Projects Enrollment to Complete in Q2 of 2029 | 웨이프 WAPE

EXCLUSIVE: Imunon Says Enrollment Momentum for Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer Exceeds Expectations; Projects Enrollment to Complete in Q2 of 2029

기사 요약

관련 종목

댓글 —